Skip to main content
. 2019 Jun 20;28(6):863–873. doi: 10.1089/jwh.2018.7318

Table 4.

Ordinal Logistic Regression Results–Bivariate Comparisons of Patient Characteristics on Intimate Partner Violence, Reproductive Coercion, Safety Card, and Sexually Transmitted Infection Discussions

  Outcome effect size unadjusted OR (95% CI)
Patient characteristics Any discussiona IPV discussion RC discussion Safety card discussion STI discussionb
Age,c years
 16–19 0.71 (0.35–1.45) 0.70 (0.37–1.34) 0.78 (0.42–1.46) 0.87 (0.46–1.63) 0.90 (0.15–5.29)
 25–29 1.03 (0.52–2.05) 1.15 (0.63–2.10) 1.08 (0.61–1.93) 1.05 (0.58–1.91) 1.19 (0.31–4.63)
Raced
 Black 2.41 (1.09–5.33) 2.67 (1.36–5.28) 2.24 (1.20–4.19) 1.06 (0.59–1.93) 7.02 (1.24–39.67)
 Other racial groupe 3.46 (1.14–10.49) 4.06 (1.64–10.05) 1.66 (0.80–3.48) 1.68 (0.79–3.59) 2.63 (0.53–13.20)
Born in the United States 0.46 (0.10–2.20) 0.21 (0.05–1.02) 0.41 (0.12–1.40) 0.94 (0.31–2.84) 0.46 (0.04–5.14)
Educationf          
 High school or less 0.60 (0.34–1.05) 0.79 (0.47–1.34) 0.57 (0.34–0.95) 0.87 (0.52–1.47) 0.60 (0.17–2.11)
Relationship statusg          
 Single/dating >1 person/other 0.94 (0.55–1.62) 1.09 (0.66–1.78) 0.51 (0.32–0.83) 1.01 (0.62–1.65) 1.80 (0.54–5.98)
Sexual partnersh
 Mostly men 1.38 (0.61–3.11) 1.22 (0.62–2.40) 1.16 (0.59–2.25) 1.08 (0.53–2.20) 0.91 (0.21–3.93)
 Mostly women, only women, equally men and women 1.20 (0.30–4.72) 2.54 (0.65–9.92) 1.11 (0.36–3.42) 0.68 (0.22–2.11) 0.37 (0.02–8.24)
Fearful of partner (in the last 3 months) 1.04 (0.55–1.98) 1.36 (0.75–2.44) 1.21 (0.68–2.15) 0.80 (0.45–1.42) 1.08 (0.32–3.61)
Recent RC (in the last 3 months) 0.59 (0.24–1.44) 1.13 (0.45–2.87) 1.25 (0.47–3.29) 0.55 (0.23–1.30) 0.95 (0.22–4.07)
Recent IPV (in the last 3 months) 0.65 (0.31–1.37) 0.57 (0.29–1.15) 0.67 (0.32–1.36) 1.39 (0.68–2.84) 0.40 (0.10–1.61)
Any lifetime IPV 0.85 (0.51–1.43) 0.95 (0.59–1.52) 0.92 (0.58–1.45) 0.92 (0.57–1.47) 1.46 (0.45–4.76)
Reason for clinic visit
Birth control other than condoms 1.63 (0.95–2.80) 1.22 (0.74–2.01) 1.61 (0.99–2.60) 1.57 (0.96–2.57) 1.90 (0.59–6.14)
 Symptoms 0.79 (0.31–2.06) 1.45 (0.58–3.65) 0.92 (0.38–2.22) 0.56 (0.24–1.29) 1.71 (0.28–10.50)
 Annual checkup 0.88 (0.51–1.52) 1.11 (0.67–1.85) 0.56 (0.35–0.91) 1.05 (0.63–1.76) 0.89 (0.26–3.04)
 STI test or treatment 0.99 (0.53–1.83) 1.10 (0.63–1.90) 1.39 (0.81–2.38) 0.63 (0.37–1.09) 1.00 (0.31–3.19)
 Otheri 0.88 (0.41–1.85) 1.23 (0.60–2.55) 1.05 (0.54–2.05) 0.93 (0.46–1.85) 1.19 (0.18–7.88)
Method of contraception
 Hidden methodk 0.68 (0.36–1.28) 0.74 (0.41–1.33) 0.66 (0.37–1.17) 0.97 (0.53–1.78) 0.95 (0.22–4.07)
 Long-acting reversible contraception 1.41 (0.49–4.05) 1.54 (0.62–3.82) 1.19 (0.51–2.77) 1.39 (0.57–3.42) 1.71 (0.28–10.50)
 Short-acting reversible contraception 0.65 (0.38–1.10) 0.64 (0.40–1.04) 0.55 (0.35–0.87) 0.86 (0.54–1.38) 0.37 (0.10–1.39)
 Condoms 1.29 (0.75–2.23) 1.03 (0.63–1.67) 1.46 (0.91–2.35) 1.36 (0.83–2.20) 1.11 (0.34–3.61)
 Withdrawal 2.29 (1.20–4.35) 1.53 (0.90–2.58) 1.80 (1.09–2.96) 1.85 (1.09–3.12) 3.26 (0.84–12.65)
 None 0.68 (0.22–2.16) 1.60 (0.46–5.53) 1.33 (0.34–5.10) 0.70 (0.24–2.00) 1.19 (0.18–7.88)
Patient did not use a condom when she wanted to, at least once 1.59 (0.81–3.08) 2.03 (1.10–3.74) 2.03 (1.15–3.58) 1.18 (0.66–2.08) 2.08 (0.61–7.09)
Condom use frequencyk
 Always 1.11 (0.55–2.22) 1.00 (0.53–1.86) 0.82 (0.45–1.49) 1.57 (0.82–3.00) 0.57 (0.10–3.38)

Summary score range: IPV = 0–3, RC = 0–6, wallet-sized safety card = 0–4, STI = 0–2.

Results in bold indicate statistical significance at p < 0.05.

a

Any discussion: summary score of any IPV discussion, any RC discussion, and any safety card discussion.

b

Responses from patients who reported a sexually transmitted infection diagnosis at clinic visit (n = 42).

c

Reference groups: 20–24 years.

d

Reference groups: White.

e

Includes American Indian, Alaska Native, Asian, Hispanic/Latina, multiracial, and other.

f

Reference groups: Some college education or college degree.

g

Reference groups: Married or dating one person.

h

Reference groups: Only men.

i

Includes colposcopy/cryotherapy, abnormal pap test, HPV vaccine, pregnancy test, other.

j

Includes LARC, Depo-Provera injection, and emergency contraception.

k

Reference groups: Sometimes, rarely, never.

LARC, long-acting reversible contraception; OR, odds ratio; HPV, Human Papillomavirus.